Acinetobacter baumannii Catabolizes Ethanolamine in the Absence of a Metabolosome and Converts Cobinamide into Adenosylated Cobamides.

Acinetobacter baumannii B12 biosynthesis bacterial microcompartments cobamide cobinamide salvaging ethanolamine ammonia-lyase ethanolamine ammonia-lyase reactivation ethanolamine catabolism metabolosome metabolosomes nucleotide loop assembly

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
30 08 2022
Historique:
pubmed: 27 7 2022
medline: 3 9 2022
entrez: 26 7 2022
Statut: ppublish

Résumé

Acinetobacter baumannii is an opportunistic pathogen typically associated with hospital-acquired infections. Our understanding of the metabolism and physiology of A. baumannii is limited. Here, we report that A. baumannii uses ethanolamine (EA) as the sole source of nitrogen and can use this aminoalcohol as a source of carbon and energy if the expression of the

Identifiants

pubmed: 35880884
doi: 10.1128/mbio.01793-22
pmc: PMC9426561
doi:

Substances chimiques

Cobamides 0
Ethanolamines 0
cobinamide 13497-85-3
Ethanolamine 5KV86114PT
Carbon 7440-44-0
Ethanolamine Ammonia-Lyase EC 4.3.1.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0179322

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM130399
Pays : United States

Références

J Bacteriol. 1993 Oct;175(19):6328-36
pubmed: 8407805
Nature. 1975 Mar 13;254(5496):150-1
pubmed: 1090845
Nucleic Acids Res. 2012 Nov 1;40(20):e156
pubmed: 22821568
Nature. 2010 Sep 23;467(7314):426-9
pubmed: 20864996
J Bacteriol. 2005 Dec;187(23):8039-46
pubmed: 16291677
Biochemistry. 2006 Dec 26;45(51):15188-96
pubmed: 17176040
EcoSal Plus. 2008 Sep;3(1):
pubmed: 26443728
J Biol Chem. 1975 Oct 25;250(20):8023-9
pubmed: 1080761
J Bacteriol. 2004 Nov;186(22):7635-44
pubmed: 15516577
J Antimicrob Chemother. 2003 Oct;52(4):629-35
pubmed: 12951337
Appl Environ Microbiol. 1976 Dec;32(6):781-91
pubmed: 827241
Plasmid. 2016 Jul;86:1-6
pubmed: 27234933
J Bacteriol. 2014 Feb;196(4):903-10
pubmed: 24336938
J Bacteriol. 2004 Sep;186(17):5708-14
pubmed: 15317775
J Bacteriol. 1951 Sep;62(3):293-300
pubmed: 14888646
mBio. 2018 Oct 2;9(5):
pubmed: 30279284
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
J Bacteriol. 2007 Jul;189(13):4555-60
pubmed: 17483216
Plasmid. 2003 Mar;49(2):169-78
pubmed: 12726770
J Bacteriol. 2001 Mar;183(5):1577-84
pubmed: 11160088
J Bacteriol. 1990 Jan;172(1):273-80
pubmed: 2403541
Mol Microbiol. 2011 Aug;81(4):952-67
pubmed: 21696461
Antimicrob Agents Chemother. 2004 Feb;48(2):612-4
pubmed: 14742218
Biochemistry. 2018 Aug 28;57(34):5076-5087
pubmed: 30071718
J Antimicrob Chemother. 2019 Sep 1;74(9):2544-2550
pubmed: 31199431
J Biol Chem. 2006 Jun 23;281(25):16971-16977
pubmed: 16636051
Methods Mol Biol. 2019;1946:107-113
pubmed: 30798549
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7509-14
pubmed: 20308536
PLoS Pathog. 2015 Nov 13;11(11):e1005278
pubmed: 26565973
J Bacteriol. 1968 Jul;96(1):215-20
pubmed: 4874308
PLoS One. 2012;7(3):e33342
pubmed: 22428024
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
J Biol Chem. 1990 Jul 25;265(21):12462-6
pubmed: 2197274
J Bacteriol. 1999 Sep;181(17):5317-29
pubmed: 10464203
mBio. 2018 Feb 20;9(1):
pubmed: 29463652
J Bacteriol. 2016 Aug 11;198(17):2318-29
pubmed: 27325678
Environ Microbiol Rep. 2011 Oct;3(5):508-17
pubmed: 23761329
mBio. 2014 Aug 05;5(4):e01313-14
pubmed: 25096877
J Bacteriol. 1989 Jun;171(6):3316-23
pubmed: 2656649
J Bacteriol. 1978 Feb;133(2):744-54
pubmed: 342507
Clin Microbiol Infect. 2006 Feb;12(2):123-30
pubmed: 16441449
J Bacteriol. 2008 Feb;190(4):1160-71
pubmed: 17981976
Clin Infect Dis. 1996 Aug;23(2):329-34
pubmed: 8842272
J Bacteriol. 2004 Feb;186(3):595-600
pubmed: 14729683
Biochemistry. 2007 Dec 4;46(48):13829-36
pubmed: 17988155
Microb Cell. 2016 Jan 18;3(2):89-91
pubmed: 28357338
J Bacteriol. 2013 Jun;195(12):2864-79
pubmed: 23585538

Auteurs

Elizabeth A Villa (EA)

Department of Microbiology, University of Georgia, Athens, Georgia, USA.

Jorge C Escalante-Semerena (JC)

Department of Microbiology, University of Georgia, Athens, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH